DETAILED ACTION
Notice of Pre-AIA or AIA Status
The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA .
Claim Rejections - 35 USC § 102
In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status.
The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action:
A person shall be entitled to a patent unless –
(a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention.
Claim(s) 39-44, 46-48, 50-54, 56-57, and 61 is/are rejected under 35 U.S.C. 102(a)(2) as being anticipated by Verma et al. (US 20200330112, henceforth Verma).
Regarding claim 39, Verma discloses a method comprising: advancing an elongate medical instrument (lead as in [0002], which is elongated object 12, fig. 2) through vasculature of a body of a subject ([0002] and fig. 2); advancing a probe (vascular snare system 10, fig. 2) through the vasculature ([0002]) and positioning a distal longitudinal probe-portion of the probe (see annotated fig. 2 calling out the distal longitudinal probe-portion of vascular snare system 10) at least partially alongside a distal longitudinal medical-instrument-portion of the elongate medical instrument (see annotated fig. 3 calling out the distal longitudinal medical-instrument-portion of elongated object 12); thereafter, mechanically coupling the distal longitudinal probe-portion to the distal longitudinal medical-instrument-portion within the body (see figs. 2 and 4); and thereafter, using the probe to bend the elongate medical instrument within the body (see fig. 4, retraction of elements 30 causes a bending of elongated object 12).
PNG
media_image1.png
714
596
media_image1.png
Greyscale
Annotated fig. 3 from Verma calling out the claimed portions
Regarding claim 40, Verma discloses the method of claim 39, wherein the distal longitudinal probe- portion includes one or more loops (first and second deployable elements 30a and 30b, fig. 4, which are considered to be loops as claimed because Merriam-Webster defines a loop to be “a curving or doubling of a line so as to form a closed or partly open curve within itself through which another line can be passed or into which a hook may be hooked”, and the curved segments of deployment elements 30 meet this definition as they are curved lines which form a partly open curve through which another line, such as elongated object 12, can be hooked), and wherein mechanically coupling comprises looping the one or more loops around the distal longitudinal medical-instrument-portion (see fig. 2, deployable elements 30 are connected and looped around the distal longitudinal medical-instrument-portion of elongated object 12).
Regarding claim 41, Verma discloses the method of claim 40, wherein looping the one or more loops around the distal longitudinal medical-instrument-portion comprises: passing the one or more loops over the distal end of the distal longitudinal medical-instrument-portion (see fig. 2 and see [0032], the manipulation of deployment elements 30 is a passing over as claimed because it involves the ends of the deployable elements moving past and around object 12); and thereafter, proximally withdrawing the distal longitudinal probe-portion (see [0035], elements 30 are proximally withdrawn through sheath 22 after magnets 32 and 34 are coupled in the body), such that the one or more loops are positioned around the distal longitudinal medical-instrument-portion (see fig. 4 which shows element 30b being positioned around the distal longitudinal medical-instrument-portion of object 12).
Regarding claim 42, Verma discloses the method of claim 40, wherein the distal longitudinal probe- portion includes two or more loops (see fig. 2, there are 2 loops which are deployment element 30a and 30b; these are each considered to be loops where they are used to form a loop), and wherein mechanically coupling comprises looping the two or more loops around the distal longitudinal medical-instrument-portion (see fig. 2, the deployment elements 30 each have to be initially manipulated to be looped around the elongated object 12; see also [0032] and [0035]).
Regarding claim 43, Verma discloses the method of claim 40, wherein mechanically coupling the distal longitudinal probe-portion to the distal longitudinal medical-instrument-portion comprises tightening the one or more loops around the distal longitudinal medical-instrument-portion (see [0035], the coupling including the tightening of loops occurs when the deployment elements are proximally retracted) after looping the one or more loops around the distal longitudinal medical-instrument-portion (see [0032] and [0035]).
Regarding claim 44, Verma discloses the method of claim 40, wherein advancing the probe through the vasculature comprises advancing the probe through the vasculature (see [0031], the system should be inserted into an access site and advanced to within close proximity to object 12 within the vasculature) while the one or more loops are in a non-radially-extended configuration (see [0031], the deployment elements are kept in sheath 22 while the sheath 22 is advanced intravascularly in the chosen method of use), and wherein mechanically coupling the distal longitudinal probe-portion to the distal longitudinal medical-instrument-portion comprises transitioning the one or more loops to a radially-extended configuration (see [0031] and [0032], the coupling requires deployment elements 30 to be advanced until they protrude out of sheath 22, which is a transitioning to a radially extended configuration as claimed).
Regarding claim 46, Verma discloses the method of claim 44, wherein the one or more loops are retracted against the probe when in the non-radially-extended configuration (see [0031], deployment elements are considered to be retracted against sheath 22 of system 10 when they are held inside of it during advancing through vasculature since they are not extended and would be in direct contact with the wall of sheath 22 inside of lumen 24).
Regarding claim 47, Verma discloses the method of claim 44, wherein transitioning the one or more loops to the radially-extended configuration comprises using one or more control wires (cables 50 and 62, see [0040], [0041], and fig. 7) that pass along the probe (see [0040] and [0041], cables 50 and 62 pass inside of lumens of deployment elements 30 which are a part of system 10 and thus pass along the system as claimed) to transition the one or more loops to the radially-extended configuration (see [0038], handles 44 and cables 50 and 62 are used for the manipulation of deployment elements 30 which are the claimed loops to move elements 30 into the desired configurations).
Regarding claim 48, Verma discloses the method of claim 44, wherein transitioning the one or more loops to the radially-extended configuration comprises pivoting the one or more loops with respect to an external surface of the probe (see [0038], manipulation of the deployment elements 30 into the proper configuration for snaring elongated object 12 includes rotation of the elements 30, which is a pivoting of elements 30, and this rotation would occur with respect to an exterior surface of sheath 22 as claimed).
Regarding claim 50, Verma discloses the method of claim 39, wherein advancing the elongate medical instrument through the vasculature comprises advancing the elongate medical instrument through the vasculature along a first route through the vasculature (see fig. 2, elongated object 12 is shown as having been moved through the heart along a first route), and wherein advancing the probe through the vasculature comprises advancing the probe through the vasculature along a second route through the vasculature (see fig. 2, system 10 is shown as having been moved through the heart along a second route), the second route different from the first route (see fig. 2, the system 10 and object 12 are shown as having been moved along different routes and meeting at a point within the heart from different directions).
Regarding claim 51, Verma discloses the method of claim 39, wherein the probe includes a steerability-providing mechanism (the combination of handles 44 and cables 50 and 62 make up a steerability-providing mechanism as claimed, see at least [0045] and fig. 7), and wherein using the probe to bend the elongate medical instrument comprises activating the steerability-providing mechanism to steer the probe (see [0045] and [0035], manipulating deployment elements 30 which is required for retraction of object 12 involves bending and thus steering of system 10 which is achieved through the use of the claimed steerability-providing mechanism).
Regarding claim 52, Verma discloses the method of claim 51, wherein the steerability-providing mechanism comprises one or more wires (cables 50 and 62, fig. 7) that pass through one or more channels (cables 50 and 62 pass through lumens of their respective deployment elements 30 which are channels, see [0040] and [0041]) defined by a wall of the probe (the lumens of elements 30 are defined by walls thereof, [0040] and [0041]), and wherein activating the steerability-providing mechanism comprises pulling at least one of the one or more wires proximally to bend the probe ([0040] and [0041]).
Regarding claim 53, Verma discloses the method of claim 52, wherein the distal longitudinal probe-portion includes one or more loops (first and second deployable elements 30a and 30b, fig. 4, which are considered to be loops as claimed because Merriam-Webster defines a loop to be “a curving or doubling of a line so as to form a closed or partly open curve within itself through which another line can be passed or into which a hook may be hooked”, and the curved segments of deployment elements 30 meet this definition as they are curved lines which form a partly open curve through which another line, such as elongated object 12, can be hooked), wherein the one or more wires are attached to or integral with the one or more loops (see [0040] and [0041], cables 50 and 62), and wherein mechanically coupling comprises looping the one or more loops around the distal longitudinal medical-instrument-portion (see fig. 2, deployable elements 30 are connected and looped around the distal longitudinal medical-instrument-portion of elongated object 12).
Regarding claim 54, Verma discloses the method of claim 39, wherein the elongate medical instrument is an intracardiac medical instrument (elongate object 12 can be a lead for a defibrillator lead which is an intracardiac medical instrument, [0002]), and wherein advancing the elongate medical instrument comprises advancing the intracardiac medical instrument through the vasculature into a heart chamber of the subject (see fig. 2, elongate object 12 is shown as being placed within a chamber of a heart 14).
Regarding claim 56, Verma discloses the method of claim 39, wherein the elongate medical instrument does not comprise a steerability-providing mechanism (see [0002], elongated object 12 can be a broken lead which would not have a steerability-providing mechanism as claimed since it is broken).
Regarding claim 57, Verma discloses the method of claim 39, wherein the elongate medical instrument is shaped so as to define at least one longitudinal channel therethrough (see Verma [0002], the elongated object 12 can be a stent, and stents have channels therethrough such as to hold blood vessels or other lumens open which is their purpose).
Regarding claim 61, Verma discloses the method of claim 39, wherein the elongate medical instrument is a therapeutic medical instrument (see [0004], elongated object 12 can be a pacemaker lead and a pacemaker is a medical instrument which delivers electrical therapy to the heart).
Claim Rejections - 35 USC § 103
The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action:
A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made.
The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows:
1. Determining the scope and contents of the prior art.
2. Ascertaining the differences between the prior art and the claims at issue.
3. Resolving the level of ordinary skill in the pertinent art.
4. Considering objective evidence present in the application indicating obviousness or nonobviousness.
Claim(s) 59-60 is/are rejected under 35 U.S.C. 103 as being unpatentable over Verma et al. (US 20200330112, henceforth Verma) as applied to claim 39 above, and further in view of Gijsbers et al. (US 20200113540, henceforth Gijsbers).
Regarding claim 59, Verma discloses the method of claim 39, and additionally discloses that “The system 10 may be utilized to extract any elongated object 12 from the vasculature of a patient”, and that “The system 10 may also be used to extract any other type of foreign object, such as an inferior vena cava filter, having a hook or similar element that can be snared by a loop” ([0029]).
Verma does not explicitly disclose the method wherein the elongate medical instrument is a diagnostic medical instrument. Gijsbers teaches use of a non-steerable diagnostic medical instrument probe inserted into the vasculature as being used beneficially to provide for detailed visualization of an interventional target region while minimizing contrast injection while creating 3D roadmaps of hearts during surgeries (see at least fig. 3B, [0027]-[0033] and [0055]).
It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to have used the system of Verma to have retrieved the probe of Gijsbers should it break during use and be needed to retrieved as the probe of Gijsbers is disposable ([0042]) and simply delivered via catheter ([0055]) and because that is the intended use of the system of Verma ([0029]).
Regarding claim 60, Verma as modified discloses the method of claim 59, wherein the diagnostic medical instrument is selected from the group consisting of: an intracardiac echocardiography (ICE) probe, a biopsy probe, and an ultrasound probe (ICE probe, see Gijsbers [0055]).
Claim(s) 62 is/are rejected under 35 U.S.C. 103 as being unpatentable over Verma et al. (US 20200330112, henceforth Verma) as applied to claim 61 above, and further in view of Starksen et al. (US 20050119523, henceforth Starksen).
Regarding claim 62, Verma discloses the method of claim 61, and additionally discloses that “The system 10 may be utilized to extract any elongated object 12 from the vasculature of a patient”, and that “The system 10 may also be used to extract any other type of foreign object, such as an inferior vena cava filter, having a hook or similar element that can be snared by a loop” ([0029]). Verma additionally discloses that the leads which it is configured for extracting can be pacing leads (Abstract).
Verma does not explicitly disclose the method wherein the therapeutic medical instrument is an ablation probe. Starksen teaches that devices which can be used with pacemaker leads can be used with cardiac ablation probes (see at least [0016] and [0033]).
It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to have used the system of Verma to have grabbed a cardiac ablation probe as its elongated object as Verma discloses that it is capable of grabbing such an elongated object ([0029]) and because Starksen teaches that medical devices meant to be used in the heart with pacemaker leads can also be used with cardiac ablation probes (see at least [0016] and [0033]).
Conclusion
The prior art made of record and not relied upon is considered pertinent to applicant's disclosure.
Ayala et al. (US 20060100544) is considered relevant prior art regarding a steerable loop which can be inserted into patient vasculature and expanded or collapsed.
Grace (US 20160184580) is considered relevant prior art regarding a snare system with multiple expandable and collapsible loops similar to those of Applicant.
Any inquiry concerning this communication or earlier communications from the examiner should be directed to SAMUEL J MARRISON whose telephone number is (703)756-1927. The examiner can normally be reached M-F 7:00a-3:30p ET.
Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice.
If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Kevin Sirmons can be reached at (571) 272-4965. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300.
Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000.
/SAMUEL J MARRISON/Examiner, Art Unit 3783 /EMILY L SCHMIDT/Primary Examiner, Art Unit 3783